Manning Paul B's Form 4 filing
Candel Therapeutics, Inc. (CADL) · filed Aug 2, 2021
- Accession no.
- 0000899243-21-031096
- Filed
- Aug 2, 2021
- Trade date
- Jul 29, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0000899243-21-031614 (Aug 4, 2021). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Manning Paul BCIK 0001494695 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2021 | Common Stock | CConversionAcquired | +679,158 | – | – | 679,158 | Indirect | |
| Jul 29, 2021 | Common Stock | CConversionAcquired | +553,752 | – | – | 553,752 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2021 | Common Stock | CConversionDisposed | −679,158 | $0.00 | $0 | 0 | Indirect | |
| Jul 29, 2021 | Common Stock | CConversionDisposed | −553,752 | $0.00 | $0 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.